Please use this identifier to cite or link to this item:
Title: Development of Human Stem Cell-Based Model for Developmental Toxicity Testing
Keywords: developmental toxicity, hPSCs, mesoendoderm differentiation, collective cell migration, micropatterning, morphometric assay
Issue Date: 23-Jan-2015
Citation: XING JIANGWA (2015-01-23). Development of Human Stem Cell-Based Model for Developmental Toxicity Testing. ScholarBank@NUS Repository.
Abstract: A human pluripotent stem cell (hPSC)-based in vitro model, which recapitulated both cell differentiation and collective cell migration during embryogenesis, was developed to identify teratogenic compounds. Mesoendoderm differentiation was first induced only to the periphery of circular micropatterned hPSC (?P-hPSC) colonies, where spatially polarized integrin adhesions competed to recruit Rho-ROCK activated myosin II away from E-cadherin mediated cell-cell junctions to promote differentiation. Next, these mesoendoderm cells underwent directed collective cell migration and formed an annular mesoendoderm pattern which was similar as in vivo. When treated with known teratogens, these two cellular processes were disrupted and the morphology of the mesoendoderm pattern was altered. By quantifying the morphological changes of the mesoendoderm pattern, the ?P-hPSC model could capture the dose-dependent effects of teratogenicity and correctly classify species-specific drug (Thalidomide) and false negative drug (D-penicillamine) in the conventional mouse embryonic stem cell test. This model offers a scalable screening platform to mitigate the risks of teratogen exposures in human.
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
XingJiangwa_A0068169R_Thesis_2015.pdf5.23 MBAdobe PDF



Page view(s)

checked on Oct 23, 2020


checked on Oct 23, 2020

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.